10:36 AM EDT, 05/15/2025 (MT Newswires) -- NRX Pharmaceuticals ( NRXP ) said Thursday that its Hope Therapeutics unit signed a $7.8 million term sheet with Universal Capital.

The proceeds will fund Hope's planned rollup of interventional psychiatry clinics, starting with the acquisitions of Dura Medical, Kadima and NeuroSpa, according to the company.

Hope expects to raise up to $10.3 million in capital from the proceeds of the term sheet and a previously announced investment.

Shares of NRX Pharmaceuticals ( NRXP ) were down 2% in recent trading.

Price: 2.23, Change: -0.04, Percent Change: -1.98